SS Innovations International (NASDAQ: SSII) has reported record second-quarter revenue of $13.9 million, a 39.4% increase from $10.0 million in the same period last year, driven by continued demand for its SSi Mantra surgical robotic system. The company’s first-half revenue reached $25.0 million, up 65.6% from $15.1 million in the prior-year period, signaling robust commercial momentum.
The growth is underpinned by a 30.4% rise in SSi Mantra installations during the quarter, bringing the total installed base to 224 systems across 12 countries. Cumulative surgeries performed using the platform reached 12,272, reflecting growing clinical adoption. The company’s telesurgery capabilities are also enhancing the system’s clinical profile, though system installations remain the primary driver of commercial growth.
Gross profit for the second quarter increased 20.0% to $7.1 million, while gross margin declined to 50.9% from 59.1% a year earlier, a result of higher costs associated with expansion. For the first half, gross profit improved 77.5% to $12.4 million, with gross margin improving compared to the same period in 2025.
Regulatory milestones could serve as significant catalysts for SSII. The company is targeting FDA clearance for SSi Mantra by the first quarter of 2027 and EU CE marking by the end of 2026. Achieving these approvals would open access to the U.S. and European markets, potentially accelerating adoption and revenue growth.
SS Innovations’ performance comes amid a broader trend of increasing interest in surgical robotics, which offer potential benefits such as improved precision, reduced patient trauma, and shorter recovery times. The company’s focus on affordability and telesurgery may differentiate it in a competitive landscape.
Investors should note that forward-looking statements in the company’s announcements are subject to risks and uncertainties, as detailed in its SEC filings. The full terms of use and disclaimers are available on the InvestorBrandNetwork website (http://IBN.fm/Disclaimer). For the latest news and updates on SSII, visit the company’s newsroom at https://ibn.fm/SSII.
